Erowid.org: Erowid Reference 6167 : Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study : Dams R, De Letter EA, Mortier KA, Cordonnier JA, Lambert WE, Piette MH, Van Calenbergh S, De Leenheer AP

Erowid References Database

Dams R, De Letter EA, Mortier KA, Cordonnier JA, Lambert WE, Piette MH, Van Calenbergh S, De Leenheer AP. “Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study”. J Anal Toxicol. 2003 July/Aug;27(5):318-22. <a name="ref">Dams R, De Letter EA, Mortier KA, Cordonnier JA, Lambert WE, Piette MH, Van Calenbergh S, De Leenheer AP.</a> <a href="/references/6167">"Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study"</a> <i>J Anal Toxicol</i>. 2003 July/Aug;27(5):318-22.
Text Abstract (this page) Full Text - English (private) Show Articles by Dams R De Letter EA Mortier KA Cordonnier JA Lambert WE Piette MH Van Calenbergh S De Leenheer AP Article IDs Erowid RefID: 6167 PubMedID: 12908947 Collections Hofmann Collection MDMA Collection All References	Abstract We present a fatal case involving the combined ingestion of amphetamine, 3,4-methylenedioxymethylamphetamine, 3,4-methylenedioxyamphetamine, and paramethoxyamphetamine. Various postmortem specimens (e.g., several blood samples, urine, and tissue samples) were analyzed to study the distribution of the compounds and their metabolites in the human body. Quantitation took place using liquid chromatography-sonic spray ionization-mass spectrometry after pretreatment with a liquid-liquid extraction. The medico-legal findings were compatible with a disseminated intravascular coagulation induced by hyperthermia caused by the simultaneous intake of the amphetamine analogues.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]